Telegraph Hill Partners
Venture capitalSan Francisco · Growth–Late Stage · 18 people tracked
Also known as TELEGRAPH HILL PARTNERS MANAGEMENT COMPANY LLC
Find your way into Telegraph Hill Partners
3,828 people in our graph share verified history with the Telegraph Hill Partners team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Telegraph Hill Partners partners with private life science, medical device, and healthcare companies that have novel technologies, a solid customer base, and innovative management teams. The firm provides growth capital to high-quality companies seeking to build and expand their organizations, offering an experienced team focused on efficiently driving growth and profitability while preserving each company's vision and integrity.
Source: firm website, verified Sep 15, 2026.
Team · 18 people
from the firm's website & curated & public directories
What they invest in
from 33 of 39 portfolio companiesBiotech ×19Healthtech ×19Medical Devices ×12Deep Tech ×10Advanced Manufacturing ×5AI & Machine Learning ×5Digital Health ×5Enterprise Software ×4
HQs:United States×27United Kingdom×1
Who they back
founder profiles across 10 portfolio companiesFounding team size:solo founder×72 founders×3
Investments · 39 tracked
founders shown can be your intro pathBy year:2026 · 22024 · 22023 · 52022 · 12021 · 32020 · 12019 · 32018 · 12017 · 32016 · 12015 · 22007 · 126 dated
Advanced ManufacturingHollister, US
Lisa Hood(Executive Officer)inDamon Terrill(Executive Officer)Matthew Lowell(Executive Officer)inKen Gelhaus(Executive Officer)Stephen Gunstream(Executive Officer, Director)
BoardAlexander Vos(Director)
Cell Microsystems develops automated instruments for cellular and molecular workflows used in life science research, including oncology, stem cell biology, and regenerative medicine.
BiotechDeep TechHardwareMedical DevicesDurham, US
Scott McGinnis(President)inNancy Allbritton(Director)Yuli Wang(Director)Matthew Megaro(Director)Gary Pace(Executive Officer, Director)Christopher Sims(Executive Officer, Director)
Board seatDeval LashkariRob Capone· per SEC Form D
Co-investorsIDEA NC
etherFAX provides cloud-based secure document delivery and fax transmission for businesses handling sensitive information.
AI & Machine LearningCloud ComputingCybersecurityEnterprise SoftwareHealthtechSaaS
Paul Banco(Co-Founder and EVP of Federal Programs)inRob Cichielo(Co-Founder and Chief Technology Officer)inJay Volk(Chief Executive Officer)inEmil Sturniolo(Chief Security Officer)inAllison Kirsch(Chief Marketing Officer)in
Magstim develops neurotechnology and neurostimulation devices for healthcare providers and researchers, focusing on neuromodulation and neurophysiology applications.
Deep TechHardwareHealthtechMedical DevicesMental HealthSan Francisco, US
BoardThomas A. Raffin(Executive Officer, Director)J. Matthew Mackowski(Executive Officer, Director)
Quanterix (operating together with Akoya) develops biomarker measurement platforms that combine ultrasensitive blood/CSF liquid immunoassays with spatial tissue proteomics for research and clinical use in neurology, oncology, inflammation, cardiology and infectious disease.
BiotechDigital HealthMedical DevicesBillerica, US
Brian McKelligon(Executive Officer)Garry Nolan(Director)Matthew Winkler(Director)
BoardRob Hart(Executive Officer)inThomas Raffin(Director)in
Board seatRobert Shepler· per SEC Form D
Co-investorsaMoon
Invisalert Solutions provides a patient safety platform using machine learning and AI to monitor and prevent adverse events such as falls, infections, and elopement across acute care, emergency departments, behavioral health, and long-term care facilities.
AI & Machine LearningEnterprise SoftwareHealthtechWest Chester, US
Pete Nagy(Executive Officer, Director)Mark Gold(Director)
BoardRegina Widdow(Director)
Board seatRob HartGary CurtisTom Raffin· per SEC Form D
Mosaic Biosciences is a biologics discovery company that advances biologic drug candidates from discovery through IND-enabling studies and clinical development, working with partners across multiple therapeutic modalities.
BiotechDeep TechBoulder, US
Marty (Martin) Stanton(Founder & former CEO)inEric Furfine(Chief Scientific Officer)inAlexei Kazantsev(Vice President Protein Design and Engineering)inTracey Mullen(Chief Strategy Officer)inScott Glaser(SVP, Biologics Discovery)inJean-Pierre Wery(Chief Executive Officer)in
Board seatJeanette WelshRob Capone· per SEC Form D
A biopharmaceutical company that discovers and develops medicines, building on immunology research to explore additional disease areas.
BiotechHealthtechMadison, US
Jigar Patel(Executive Officer, Director)in
Board seatDeval LashkariRob Hart· per SEC Form D
Panome Bio provides metabolomics, proteomics, and multi-omics integration workflows along with a computational platform that analyzes and integrates diverse biological data types.
AI & Machine LearningBiotechDeep TechHealthtechSaint Louis, US
Edward Weinstein(Executive Officer, Director)inTom Cohen(Executive Officer)in
BoardDavid Smoller(Director)inAlexander Herzick(Director)in
Board seatDeval LashkariRob Capone· per SEC Form D
Co-investorsBioGenerator VenturesCultivation Capital
Seattle, US
Ronald Seubert(Executive Officer, Director, Promoter)Evan Castiglia(Executive Officer)inJoseph Victor(Executive Officer, Director)Frank Witney(Director)Eric Kaldjian(Executive Officer)
Board seatRobert Shepler· per SEC Form D
Co-investors5AM VenturesArboretum VenturesF-Prime CapitalSofinnova Ventures
Argonaut Manufacturing Services provides contract manufacturing for life sciences and healthcare products, serving partners across the health and biotech industries with expertise in cGMP manufacturing, regulatory affairs, and operational scaling.
Advanced ManufacturingBiotechEnterprise SoftwareHealthtechSaaSBoston, US
Rick(CEO)
Carterra designs and manufactures flexible microfluidic manufacturing systems for the life sciences and biotech research markets.
BiotechDeep TechMedical DevicesNew MaterialsSan Diego, US
Mr. Eckman(Founder)
DYNEX Technologies develops and manufactures automated ELISA and chemiluminescence microplate instruments for clinical and diagnostic laboratories.
HealthtechMedical Devices
Co-investorsAmpersand
Emerging Therapy Solutions provides comprehensive management solutions for cell and gene therapies and transplants to payers, self-insured employers, and secondary payers.
HealthtechInsurTechMedical Devices
David J. McLean
Co-investorsWe Ventures
GrayHawk Health provides in-home and virtual medical care combined with individual health coaching for high-risk, older community members, coordinating clinical, social, and behavioral health needs.
Digital HealthHealthtechWellness & FitnessWayne, US
Andrew Henderson II(Executive Officer, Director)inRaymond Falci(Director)Marc Watkins(Director)Rob Hart(Director)in
Thomson manufactures laboratory consumables including filter vials, shake flasks, well plates, and chromatography columns for pharmaceutical, biotech, environmental, toxicology, and contract manufacturing sectors.
Advanced ManufacturingBiotechHealthtechMedical Devices
Melissa Ellis(Founder Emeritus)in
Kytopen develops non-viral gene delivery technology called Flowfect that combines fluid flow with electric fields to deliver payloads such as mRNA, DNA, and CRISPR Cas9 RNP into cells for high-throughput transfection.
BiotechDeep TechHardwareCambridge, US
Cullen Buie(Director)inPaulo Garcia(Executive Officer, Director, Promoter)inMichael Chiu(Director, Executive Officer)in
BoardPaxton Major(Director)inAnn DeWitt(Director)inPaul Wotton(Director)
Co-investorsBantam GroupHorizons VenturesMassVenturesSelvedge VentureTBD AngelsThe Engine Ventures+2 more
Nivagen provides drug product development services, guiding pharmaceutical companies through the full lifecycle from concept to commercialization, including traditional NDAs, 505(b)(2)s, and complex generics.
Advanced ManufacturingBiotechDigital HealthHealthtechMedical DevicesCalifornia, US
Dr. Nirav Patel
Promptly is a patient experience and engagement software suite for specialty medical practices, offering tools to automate practice operations and appointment scheduling.
Digital HealthEnterprise SoftwareHealthtechSaaS
RevMedica develops smart surgical stapling and soft tissue management systems for minimally invasive and robotic procedures, designed to provide real-time intraoperative data and improve clinical decision-making for surgeons.
AI & Machine LearningHealthtechMedical DevicesMiddletown, US
Thomas Wenchell(Chief Executive Officer and Co-Founder)inC. Robert Satti(Director)
Co-investorsConnecticut Innovations
HealthtechMountain View, US
Paul Rhodes(Executive Officer, Director)Ray Martino(Director)Paul Grossman(Director)in
TrakCel develops technology solutions for clinical trial services and cell therapy supply chain management, including cold chain logistics and software platforms for advanced therapy deployment.
BiotechHealthtechLogistics & Supply ChainMedical DevicesSaaSWales, GB
Dr Matthew Lakelin(Head of Consultancy Services & Co-Founder)Ravi Nalliah(Chief Executive Officer)inDr Akshay Peer(Chief Product Officer)
Co-investorsCencora Ventures
Welcony is a healthcare technology company that brings together four brands—Magstim, EGI, Technomed, and Neurosign—to make neurotechnology products including Transcranial Magnetic Stimulation (TMS), high-density EEG, neuromonitoring, and clinical neurophysiology accessories.
Deep TechHealthtechMedical Devices
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Aquaro HistologyArgonaut Manufacturing ServicesCommunity BioEmerging Therapy SolutionsPrecision NanoSystemsCarterraExcellosFrontier PsychiatryLDR HoldingNivagen PharmaceuticalsWasatch Microfluidics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 2
1 IPOs · 1 acquisitionsAlpha TeknovaNASDAQ: TKNOAkoyabioacq. by Quanterix
Portfolio news
latest coverage across their companiesFrontier · investing.com · Sep 9, 2026
Alpha Teknova · seekingalpha.com · Aug 24, 2026
Teknova · finance.yahoo.com · Aug 20, 2026
ETHERFAX · streetinsider.com · Jun 17, 2026
Kytopen · nationaltoday.com · Apr 10, 2026
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| Alpha Teknova | 64.6% | $16.00 | Jun 2021 | $280.2M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Public market activity · per SEC filings
what is this? ⓘDisclosed stake · filed Feb 2016
Disclosed stake · filed Jan 2015
Disclosed stake · filed Feb 2014
7 insider ownership filings (Forms 3/4/5)
at Alpha Teknova, Inc. (TKNO)
Files 13F institutional holdings reports · latest Jan 2016
From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.
Frequently asked questions
- How many investments has Telegraph Hill Partners made?
- Telegraph Hill Partners has 39 tracked investments, 2 of which have exited, including 3 dated in the last 24 months.
- What stage does Telegraph Hill Partners invest at?
- Telegraph Hill Partners invests at the Growth, Late Stage stages.
- What is Telegraph Hill Partners's typical check size?
- Telegraph Hill Partners typically writes checks of $2M – $8M.
- What sectors does Telegraph Hill Partners focus on?
- Telegraph Hill Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Telegraph Hill Partners located?
- Telegraph Hill Partners is headquartered in San Francisco, US.
- Does Telegraph Hill Partners lead rounds?
- Yes, Telegraph Hill Partners leads investment rounds.
- Who does Telegraph Hill Partners co-invest with?
- Telegraph Hill Partners most often shares deals with aMoon, BioGenerator Ventures, Connecticut Innovations, among 12 tracked co-investors.
Images
Co-investors · 1
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.
Firms observed investing alongside Telegraph Hill Partners, from public investor directories. Shared companies are the overlap with Telegraph Hill Partners's recorded portfolio.
Similar investors
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Sofinnova is an investment firm focused on the life sciences and biotechnology sector, partnering with companies from inception through drug development, regulatory approval, company building, and IPO.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.